Integral Health Asset Management as of June 30, 2023
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 73 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Cigna Corp (CI) | 6.3 | $51M | 180k | 280.60 | |
Zimmer Holdings (ZBH) | 5.4 | $44M | 300k | 145.60 | |
Novo-nordisk A S Put Put Option | 5.0 | $41M | 250k | 161.83 | |
Inspire Med Sys (INSP) | 4.1 | $33M | 103k | 324.64 | |
McKesson Corporation (MCK) | 3.8 | $31M | 72k | 427.31 | |
Boston Scientific Corporation (BSX) | 3.1 | $25M | 466k | 54.09 | |
Cytokinetics Com New (CYTK) | 2.6 | $21M | 650k | 32.62 | |
Cooper Cos Com New | 2.5 | $20M | 52k | 383.43 | |
Tenet Healthcare Corp Com New (THC) | 2.3 | $19M | 232k | 81.38 | |
PerkinElmer (RVTY) | 2.1 | $17M | 140k | 118.79 | |
Argenx Se Sponsored Adr (ARGX) | 1.9 | $16M | 40k | 389.73 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.9 | $15M | 300k | 51.00 | |
Encompass Health Corp (EHC) | 1.8 | $15M | 220k | 67.71 | |
Guardant Health (GH) | 1.8 | $15M | 412k | 35.80 | |
Hologic (HOLX) | 1.8 | $14M | 175k | 80.97 | |
Eli Lilly & Co. (LLY) | 1.7 | $14M | 30k | 468.98 | |
Centene Corporation (CNC) | 1.7 | $14M | 200k | 67.45 | |
Abbvie (ABBV) | 1.7 | $14M | 100k | 134.73 | |
Anthem (ELV) | 1.7 | $13M | 30k | 444.29 | |
Schrodinger (SDGR) | 1.6 | $13M | 265k | 49.92 | |
Zentalis Pharmaceuticals (ZNTL) | 1.6 | $13M | 450k | 28.21 | |
GSK Sponsored Adr (GSK) | 1.5 | $13M | 350k | 35.64 | |
Intuitive Surgical Com New (ISRG) | 1.5 | $12M | 36k | 341.94 | |
Reata Pharmaceuticals Cl A | 1.5 | $12M | 120k | 101.96 | |
Hca Holdings (HCA) | 1.5 | $12M | 40k | 303.48 | |
Danaher Corporation (DHR) | 1.5 | $12M | 50k | 240.00 | |
Johnson & Johnson (JNJ) | 1.5 | $12M | 72k | 165.52 | |
Viking Therapeutics (VKTX) | 1.5 | $12M | 730k | 16.21 | |
Ventyx Biosciences (VTYX) | 1.4 | $12M | 350k | 32.80 | |
Surgery Partners (SGRY) | 1.4 | $11M | 250k | 44.99 | |
Novartis Sponsored Adr (NVS) | 1.3 | $10M | 103k | 100.91 | |
Replimune Group (REPL) | 1.3 | $10M | 445k | 23.22 | |
Penumbra (PEN) | 1.3 | $10M | 30k | 344.06 | |
Alnylam Pharmaceuticals (ALNY) | 1.2 | $9.9M | 52k | 189.94 | |
Revolution Medicines (RVMD) | 1.2 | $9.5M | 356k | 26.75 | |
Inari Medical Ord (NARI) | 1.1 | $9.0M | 155k | 58.14 | |
Intra Cellular Therapies (ITCI) | 1.1 | $9.0M | 142k | 63.32 | |
Alkermes SHS (ALKS) | 1.1 | $8.9M | 284k | 31.30 | |
Relay Therapeutics (RLAY) | 1.1 | $8.8M | 700k | 12.56 | |
Intellia Therapeutics (NTLA) | 1.0 | $8.4M | 206k | 40.78 | |
EXACT Sciences Corporation (EXAS) | 1.0 | $8.3M | 88k | 93.90 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.9 | $7.5M | 1.0M | 7.53 | |
Krystal Biotech (KRYS) | 0.9 | $7.3M | 62k | 117.40 | |
Ptc Therapeutics I (PTCT) | 0.9 | $7.1M | 174k | 40.67 | |
Lifestance Health Group (LFST) | 0.9 | $7.1M | 773k | 9.13 | |
Medtronic SHS (MDT) | 0.9 | $7.0M | 80k | 88.10 | |
Apellis Pharmaceuticals (APLS) | 0.8 | $6.6M | 72k | 91.10 | |
Revance Therapeutics (RVNC) | 0.8 | $6.3M | 250k | 25.31 | |
Tg Therapeutics (TGTX) | 0.8 | $6.2M | 250k | 24.84 | |
Si-bone (SIBN) | 0.8 | $6.1M | 227k | 26.98 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.7 | $5.6M | 100k | 56.14 | |
Privia Health Group (PRVA) | 0.6 | $5.2M | 200k | 26.11 | |
Envista Hldgs Corp (NVST) | 0.6 | $5.1M | 150k | 33.84 | |
Teladoc (TDOC) | 0.6 | $5.1M | 200k | 25.32 | |
AmerisourceBergen (COR) | 0.6 | $5.0M | 26k | 192.43 | |
Amicus Therapeutics (FOLD) | 0.6 | $4.9M | 387k | 12.56 | |
Longboard Pharmaceuticals In | 0.5 | $4.4M | 598k | 7.34 | |
Cross Country Healthcare (CCRN) | 0.5 | $4.4M | 155k | 28.08 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $4.3M | 50k | 86.68 | |
Dentsply Sirona (XRAY) | 0.5 | $4.0M | 100k | 40.02 | |
Biontech Se Sponsored Ads (BNTX) | 0.5 | $3.9M | 36k | 107.93 | |
Sage Therapeutics (SAGE) | 0.5 | $3.8M | 80k | 47.02 | |
Prothena Corp SHS (PRTA) | 0.4 | $3.6M | 52k | 68.28 | |
Akero Therapeutics (AKRO) | 0.4 | $3.3M | 70k | 46.69 | |
Walgreens Boots Alliance Call Call Option | 0.4 | $2.8M | 100k | 28.49 | |
Uniqure Nv Call Call Option | 0.3 | $2.3M | 200k | 11.46 | |
Supernus Pharmaceuticals (SUPN) | 0.3 | $2.3M | 75k | 30.06 | |
Keros Therapeutics (KROS) | 0.3 | $2.1M | 52k | 40.18 | |
Protagonist Therapeutics (PTGX) | 0.3 | $2.1M | 75k | 27.62 | |
Allogene Therapeutics (ALLO) | 0.3 | $2.0M | 412k | 4.97 | |
Elanco Animal Health (ELAN) | 0.2 | $2.0M | 200k | 10.06 | |
Terns Pharmaceuticals (TERN) | 0.2 | $1.6M | 180k | 8.75 | |
Dyne Therapeutics (DYN) | 0.1 | $698k | 62k | 11.25 |